
Yevorab D 30mg/20mg Capsule SR
Marketer
Glacia Life Care
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Yevorab D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) can be managed with the combination medication Yevorab D 30mg/20mg SR Capsules. This medication alleviates symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion, thus easing discomfort. As prescribed, take Yevorab D 30mg/20mg SR Capsules on an empty stomach, adhering to your doctor's dosage and duration recommendations. Your prescribed dose will be tailored to your condition and response. Consistent use, as directed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all other medications you are currently using, as interactions are possible. Common, typically transient side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately to your physician. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until the medication's impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments—such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate—may enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Yevorab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Yevorab D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Yevorab D 30mg/20mg sustained-release capsule whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Yevorab D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Yevorab D 30mg/20mg Capsule SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the Yevorab D 30mg/20mg Capsule SR whole; avoid chewing, crushing, or fracturing. Consume on an empty stomach.
How Yevorab D 30mg/20mg Capsule SR works:
Yevorab D SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with a proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating smoother food passage. Rabeprazole decreases stomach acid production, providing relief from acid indigestion and heartburn.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Yevorab D 30mg/20mg SR Capsules with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The extended-release Yevorab D 30mg/20mg capsule may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Yevorab D 30mg/20mg capsule is likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Yevorab D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Yevorab D 30mg/20mg sustained-release capsules. Dosage modification of Yevorab D 30mg/20mg sustained-release capsules may be necessary. Medical advice is recommended.
LiverCAUTION
Patients with liver impairment should exercise caution when using Yevorab D 30mg/20mg sustained-release capsules. Dosage modification may be necessary; physician consultation is advised. Yevorab D 30mg/20mg sustained-release capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Yevorab D 30mg/20mg Capsule SR :
Should you forget a Yevorab D 30mg/20mg SR Capsule dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Yevorab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
